Director, New Product Planning (NPP)
Alkermes
Summary
This position offers a candidate the opportunity to significantly contribute to the long-term commercial success of the portfolio. This position is responsible for providing commercially oriented guidance to early stage product opportunities through deep understanding of markets and ability to influence in matrixed organization.
Job description
Key Responsibilities
- Develop forward-looking strategies, market positioning and product profiles for pipeline products by synthesizing primary and secondary inputs that will inform the development and lifecycle plan
- Co-lead (with development colleague) product teams through clinical development phases, working in conjunction with internal business partners (e.g. clinical, translational medicine, regulatory, research, commercial, CMC) to optimize the market value of asset
- Drive completion of NPP and market research initiatives, working closely with market research colleagues and the project teams
- Proactively monitor and generate insights from market developments and competitive landscape and incorporate insights across multiple perspectives (e.g. commercial, managed markets, clinical, and scientific)
- Generate market assessments, TPPs, and early forecasts to prioritize commercial indications for products in key therapeutic areas
Basic Requirements and Education
- Bachelor’s degree or equivalent; advanced science degree preferred
- 8 to 10+ years of pharmaceutical industry and/or consulting experience with extensive experience in commercially oriented roles, e.g. NPP, specialty pharmaceutical marketing strategy, market research.
- Experience in neuroscience preferred
- Extensive knowledge of new product development and planning/commercialization, including understanding of therapeutic markets from multiple customer perspectives (e.g., HCP, Payers, Patients) and different business perspectives (e.g., clinical, R&D, marketing)
Preferred Skills and Knowledge Requirements
- Strong ability to work, influence, and gain consensus across multiple functions (e.g. research, clinical, regulatory, translational medicine)
- Leadership presence and ability to interact effectively with multiple levels of the organization
- Significant analytic skills, able to clearly interpret and distill scientific, clinical and commercial information
- Understanding of key marketing and market research principles
- Proficiency with secondary research and databases
- Ability to effectively plan, prioritize, execute, follow up and anticipate challenges
- Excellent organization, communication (written and oral) and facilitation skills
- Self-motivated, builds trust easily and operates with integrity and ethics
- Demonstrated learning agility
- Strong history of delivering high quality, sustainable results using skills and capabilities
Travel Requirements: Occasional travel 10%
Requirements
- Bachelor’s degree or equivalent
- 8 to 10+ years of pharmaceutical industry and/or consulting experience
- Extensive experience in commercially oriented roles (e.g. NPP, specialty pharmaceutical marketing strategy, market research)
- Extensive knowledge of new product development and planning/commercialization
- Understanding of therapeutic markets from multiple customer perspectives (HCP, Payers, Patients)
- Strong ability to work, influence, and gain consensus across multiple functions
- Leadership presence and ability to interact effectively with multiple levels of the organization
- Significant analytic skills
- Understanding of key marketing and market research principles
- Proficiency with secondary research and databases
- Excellent organization, communication and facilitation skills
- Self-motivated, builds trust easily and operates with integrity and ethics
- Demonstrated learning agility
Benefits
- Performance pay bonus
- Hybrid working environment
- Competitive benefits package
Company overview
Alkermes plc is a global biopharmaceutical company specializing in neuroscience-focused medicines for psychiatric and neurological disorders. Founded in 1987 and headquartered in Dublin, Ireland, the company maintains a significant research and development center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Alkermes has established itself as a leader in developing treatments for complex conditions including schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. The company's portfolio includes proprietary commercial products such as Lybalvi (olanzapine/samidorphan), Aristada (aripiprazole lauroxil), and Vivitrol (naltrexone), alongside a robust pipeline of clinical and preclinical candidates targeting neurological disorders like narcolepsy and idiopathic hypersomnia. With approximately 1,800-2,100 employees worldwide, Alkermes combines deep neuroscience expertise with sophisticated development capabilities to address traditionally overlooked or stigmatized conditions, maintaining a patient-centered approach to drug development and commercialization.